Nicole Ford

Dr. Nicole Ford

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2024 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
NFNicole Ford
Nicole Ford
AAAbraham Agedew
Abraham Agedew
ADAlexandra F. Dalton
Alexandra F. Dalton
JSJordan Singleton
Jordan Singleton
CPCria G. Perrine
Cria G. Perrine
SSSharon Saydah
Sharon Saydah
This report describes the prevalence of adults who reported ever experiencing Long COVID.

11 September 2015 in Journal of Developmental Origins of Health and Disease
Verified
Journal Article
Closed access
PDF file
NFNicole Ford
Nicole Ford
ASA. D. Stein
A. D. Stein
An estimated 200 million children worldwide fail to meet their development potential due to poverty, poor health and unstimulating environments. Missing developmental milestones has lasting effects on adult human capital. Africa has a large burden of risk factors for poor child development. The objective of this paper is to identify scope for improvement at the country level in three domains – nutrition, environment, and mother–child interactions. We used nationally representative data from large-scale surveys, data repositories and country reports from 2000 to 2014. Overall, there was heterogeneity in performance across domains, suggesting that each country faces distinct challenges in addressing risk factors for poor child development. Data were lacking for many indicators, especially in the mother–child interaction domain. There is a clear need to improve routine collection of high-quality, country-level indicators relevant to child development to assess risk and track progress.

27 April 2020 in Maternal & Child Nutrition
Verified
Journal Article
Open access
PDF file
NFNicole Ford
Nicole Ford
RBRam Padarth Bichha
Ram Padarth Bichha
KPKedar Raj Parajuli
Kedar Raj Parajuli
NPNaveen Paudyal
Naveen Paudyal
NJNira Joshi
Nira Joshi
MJMaria Elena Jefferds
Maria Elena Jefferds
We used data from the 2016 Nepal National Micronutrient Status Survey to evaluate factors associated with anaemia (World Health Organization cut‐points using altitude‐ and smoking‐adjusted haemoglobin [Hb]) among nationally representative samples of adolescents 10–19 years. Hb, biomarkers of micronutrients, infection and inflammation were assessed from venous blood. Sociodemographic and household characteristics, dietary diversity, pica and recent morbidity were ascertained by interview. We explored bivariate relationships between candidate predictors and anaemia among boys (N = 967) and girls (N = 1,680). Candidate predictors with P < 0.05 in bivariate analyses were included in sex‐specific multivariable logistic regression models. Anaemia prevalence was 20.6% (95% confidence interval [CI] [17.1, 24.1]) among girls and 10.9% (95% CI [8.2, 13.6]) among boys. Among girls, living in the Mountain and Hill ecological zones relative to the Terai (adjusted odds ratio [AOR] 0.28, 95% CI [0.15, 0.52] and AOR 0.42, 95% CI [0.25, 0.73], respectively), ln ferritin (μg/L) (AOR 0.53, 95% CI [0.42, 0.68]) and ln retinol binding protein (RBP) (μmol/L) (AOR 0.08, 95% CI [0.04, 0.16]) were associated with reduced anaemia odds. Older age (age in years AOR 1.19, 95% CI [1.12, 1.27]) and Janajati ethnicity relative to the Muslim ethnicity (AOR 3.04, 95% CI [1.10, 8.36]) were associated with higher anaemia odds. Among boys, ln RBP [μmol/L] (AOR 0.25, 95% CI [0.10, 0.65]) and having consumed flesh foods (AOR 0.57, 95% CI [0.33, 0.99]) were associated with lower anaemia odds. Open defecation (AOR 2.36, 95% CI [1.15, 4.84]) and ln transferrin receptor [mg/L] (AOR 3.21, 95% CI [1.25, 8.23]) were associated with increased anaemia odds. Anaemia among adolescents might be addressed through effective public health policy and programs targeting micronutrient status, diet and sanitation.

3 May 2022 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
NFNicole Ford
Nicole Ford
CRCheryl L Robbins
Cheryl L Robbins
DHDonald K Hayes
Donald K Hayes
JKJean Y Ko
Jean Y Ko
FLFleetwood Loustalot
Fleetwood Loustalot
BACKGROUND: To explore the prevalence, pharmacologic treatment, and control of hypertension among US nonpregnant women of reproductive age by race/Hispanic origin to identify potential gaps in care. METHODS: We pooled data from the 2011 to March 2020 (prepandemic) National Health and Nutrition Examination Survey cycles. Our analytic sample included 4,590 nonpregnant women aged 20–44 years who had at least 1 examiner-measured blood pressure (BP) value. We estimated prevalences and 95% confidence intervals (CIs) of hypertension, pharmacologic treatment, and control based on the 2003 Joint Committee on High Blood Pressure (JNC 7) and the 2017 American College of Cardiology and the American Heart Association (ACC/AHA) guidelines. We evaluated differences by race/Hispanic origin using Rao–Scott chi-square tests. RESULTS: Applying ACC/AHA guidelines, hypertension prevalence ranged from 14.0% (95% CI: 12.0, 15.9) among Hispanic women to 30.9% (95% CI: 27.8, 34.0) among non-Hispanic Black women. Among women with hypertension, non-Hispanic Black women had the highest eligibility for pharmacological treatment (65.5%, 95% CI: 60.4, 70.5); current use was highest among White women (61.8%, 95% CI: 53.8, 69.9). BP control ranged from 5.2% (95% CI: 1.1, 9.3) among women of another or multiple non-Hispanic races to 18.6% (95% CI: 12.1, 25.0) among Hispanic women. CONCLUSIONS: These findings highlight the importance of monitoring hypertension, pharmacologic treatment, and control by race/Hispanic origin and addressing barriers to equitable hypertension care among women of reproductive age.

1 April 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
NFNicole Ford
Nicole Ford
CDCarla L. DeSisto
Carla L. DeSisto
RGRomeo R. Galang
Romeo R. Galang
EKElena V. Kuklina
Elena V. Kuklina
LSLaurence Sperling
Laurence Sperling
JKJean Y. Ko
Jean Y. Ko
Estimates of cardiac arrest occurring during delivery guide evidence-based strategies to reduce pregnancy-related death. To investigate rate of, maternal characteristics associated with, and survival after cardiac arrest during delivery hospitalization. Retrospective cohort study. U.S. acute care hospitals, 2017 to 2019. Delivery hospitalizations among women aged 12 to 55 years included in the National Inpatient Sample database. Delivery hospitalizations, cardiac arrest, underlying medical conditions, obstetric outcomes, and severe maternal complications were identified using codes from the International Classification of Diseases, 10th Revision, Clinical Modification. Survival to hospital discharge was based on discharge disposition. Among 10 921 784 U.S. delivery hospitalizations, the cardiac arrest rate was 13.4 per 100 000. Of the 1465 patients who had cardiac arrest, 68.6% (95% CI, 63.2% to 74.0%) survived to hospital discharge. Cardiac arrest was more common among patients who were older, were non-Hispanic Black, had Medicare or Medicaid, or had underlying medical conditions. Acute respiratory distress syndrome was the most common co-occurring diagnosis (56.0% [CI, 50.2% to 61.7%]). Among co-occurring procedures or interventions examined, mechanical ventilation was the most common (53.2% [CI, 47.5% to 59.0%]). The rate of survival to hospital discharge after cardiac arrest was lower with co-occurring disseminated intravascular coagulation (DIC) without or with transfusion (50.0% [CI, 35.8% to 64.2%] or 54.3% [CI, 39.2% to 69.5%], respectively). Cardiac arrests occurring outside delivery hospitalizations were not included. The temporality of arrest relative to the delivery or other maternal complications is unknown. Data do not distinguish cause of cardiac arrest, such as pregnancy-related complications or other underlying causes among pregnant women. Cardiac arrest was observed in approximately 1 in 9000 delivery hospitalizations, among which nearly 7 in 10 women survived to hospital discharge. Survival was lowest during hospitalizations with co-occurring DIC. None.

1 November 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
NFNicole Ford
Nicole Ford
RMReynaldo Martorell
Reynaldo Martorell
NMNeil K Mehta
Neil K Mehta
MRManuel Ramirez-Zea
Manuel Ramirez-Zea
ASAryeh D Stein
Aryeh D Stein
Background: Latin America has experienced increases in obesity. Little is known about the role of early life factors on body mass index (BMI) gain ove